Integrating Clinical Phenotype and Gene Expression Data to Prioritize Novel Drug Uses.

Abstract excerpt

Drug repositioning has been based largely on genomic signatures of drugs and diseases. One challenge in these efforts lies in connecting the molecular signatures of drugs into clinical responses, including therapeutic and side effects, to the repurpose of drugs. We addressed this challenge by evaluating drug-drug relationships using a phenotypic and molecular-based approach that integrates therapeutic...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Algorithms
• Share to Drug Interactions
• Share to Drug Repositioning